ACTengine® IMA203 Combined With mRNA-4203

Clinical trial NCT06946225 · RECRUITING

Trial details

NCT number: NCT06946225
Sponsor: Immatics US, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Melanoma Synovial Sarcoma

Start date: 2025-07-25
Primary completion: 2029-08-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.